We a good story
Quick delivery in Europe
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progres des recherches pharmaceutiques by E. Jucker

Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progres des recherches pharmaceutiques - Ebook

About Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progres des recherches pharmaceutiques

Volume 41 of "e;Progress in Orug Research"e; contains eight reviews and the various indexes which facilitate its use and establish the con- nection with the previous volumes. The articles in this volume deal with teratogenesis; nephrotoxicity; bacterial resistance to P. lactam antibiotics; eradication of diseases by vaccination; chirality and drug design; endogenous digitalis-like factors; erythropoietin; and sero- tonin (5HT)-antagonists. 3 All these articles give an excellent overview of the respective fields of research. In the 33 years that POR has existed, the Editor has enjoyed the valu- able help and advice of many colleagues. Readers, the authors of the reviews, and last but not least, the reviewers have all contributed greatly to the success of this series. Although the comments received so far have generally been favorable, it is nevertheless necessary to analyze and to reassess the current position and the future direction of such a review series. So far, it has been the Editors intention to help disseminate informa- tion on the vast domain of drug research, and to provide the reader with a tool with which to keep abreast of the latest developments and trends. The reviews in POR are useful to the non-specialists, who can obtain an overview of a particular field of research in a relatively short time. The specialist readers of POR will appreciate the reviews' comprehensive bibliographies, and, in addition, they may even get fresh impulses for their own research.

Show more
  • Language:
  • English
  • ISBN:
  • 9783034871501
  • Protection:
  • DRM
  • Published:
  • March 8, 2013
  • £69.49
  • 4-7 business days
Description of Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progres des recherches pharmaceutiques
Volume 41 of "e;Progress in Orug Research"e; contains eight reviews and the various indexes which facilitate its use and establish the con- nection with the previous volumes. The articles in this volume deal with teratogenesis; nephrotoxicity; bacterial resistance to P. lactam antibiotics; eradication of diseases by vaccination; chirality and drug design; endogenous digitalis-like factors; erythropoietin; and sero- tonin (5HT)-antagonists. 3 All these articles give an excellent overview of the respective fields of research. In the 33 years that POR has existed, the Editor has enjoyed the valu- able help and advice of many colleagues. Readers, the authors of the reviews, and last but not least, the reviewers have all contributed greatly to the success of this series. Although the comments received so far have generally been favorable, it is nevertheless necessary to analyze and to reassess the current position and the future direction of such a review series. So far, it has been the Editors intention to help disseminate informa- tion on the vast domain of drug research, and to provide the reader with a tool with which to keep abreast of the latest developments and trends. The reviews in POR are useful to the non-specialists, who can obtain an overview of a particular field of research in a relatively short time. The specialist readers of POR will appreciate the reviews' comprehensive bibliographies, and, in addition, they may even get fresh impulses for their own research.
User ratings of Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progres des recherches pharmaceutiques


Find similar books
The book Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progres des recherches pharmaceutiques can be found in the following categories:
Join thousands of book lovers

Sign up to our newsletter and receive discounts and inspiration for your next reading experience.